Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Caron

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Nature Genetics|August 4, 2015
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Amit P Bhavsar, Henk Visscher, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2020
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapyAndrea Ferrari, Johannes H M Merks, Julia C Chisholm, et al.
JCO Precision Oncology|May 26, 2021
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease PanelEsther M van Wezel, Lieke M J van Zogchel, Jalenka van Wijk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumorsSean Carlin, Rob J Mairs, Anthony G McCluskey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter StudySarah C Clement, Antoinette Y N Schouten-van Meeteren, Annemieke M Boot, et al.
JAMA|June 28, 2007
Medical assessment of adverse health outcomes in long-term survivors of childhood cancerMaud M Geenen, Mathilde C Cardous-Ubbink, Leontien C M Kremer, et al.
Endocrine Connections|November 8, 2018
Declining free thyroxine levels over time in irradiated childhood brain tumor survivorsLaura van Iersel, Sarah C Clement, Antoinette Y N Schouten-van Meeteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in childrenHenk Visscher, Colin J D Ross, S Rod Rassekh, et al.
Nature|February 28, 2012
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genesJan J Molenaar, Jan Koster, Danny A Zwijnenburg, et al.
Pediatric Blood & Cancer|October 16, 2018
Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcomaBas Vaarwerk, Reineke A Schoot, Heleen Maurice-Stam, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Nature Genetics|August 4, 2015
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerFolefac Aminkeng, Amit P Bhavsar, Henk Visscher, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2020
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapyAndrea Ferrari, Johannes H M Merks, Julia C Chisholm, et al.
JCO Precision Oncology|May 26, 2021
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease PanelEsther M van Wezel, Lieke M J van Zogchel, Jalenka van Wijk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Development of a real-time polymerase chain reaction assay for prediction of the uptake of meta-[(131)I]iodobenzylguanidine by neuroblastoma tumorsSean Carlin, Rob J Mairs, Anthony G McCluskey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter StudySarah C Clement, Antoinette Y N Schouten-van Meeteren, Annemieke M Boot, et al.
JAMA|June 28, 2007
Medical assessment of adverse health outcomes in long-term survivors of childhood cancerMaud M Geenen, Mathilde C Cardous-Ubbink, Leontien C M Kremer, et al.
Endocrine Connections|November 8, 2018
Declining free thyroxine levels over time in irradiated childhood brain tumor survivorsLaura van Iersel, Sarah C Clement, Antoinette Y N Schouten-van Meeteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in childrenHenk Visscher, Colin J D Ross, S Rod Rassekh, et al.
Nature|February 28, 2012
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genesJan J Molenaar, Jan Koster, Danny A Zwijnenburg, et al.
Pediatric Blood & Cancer|October 16, 2018
Psychosocial well-being of long-term survivors of pediatric head-neck rhabdomyosarcomaBas Vaarwerk, Reineke A Schoot, Heleen Maurice-Stam, et al.
Pageof 25